294 related articles for article (PubMed ID: 26315541)
1. MicroRNA-424 inhibits Akt3/E2F3 axis and tumor growth in hepatocellular carcinoma.
Yang H; Zheng W; Shuai X; Chang RM; Yu L; Fang F; Yang LY
Oncotarget; 2015 Sep; 6(29):27736-50. PubMed ID: 26315541
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
[TBL] [Abstract][Full Text] [Related]
4. miR-363 inhibits the growth, migration and invasion of hepatocellular carcinoma cells by regulating E2F3.
Ye J; Zhang W; Liu S; Liu Y; Liu K
Oncol Rep; 2017 Dec; 38(6):3677-3684. PubMed ID: 29039555
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma.
Xiao F; Zhang W; Chen L; Chen F; Xie H; Xing C; Yu X; Ding S; Chen K; Guo H; Cheng J; Zheng S; Zhou L
J Transl Med; 2013 Aug; 11():195. PubMed ID: 23967867
[TBL] [Abstract][Full Text] [Related]
6. miR-144 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting E2F3.
Cao T; Li H; Hu Y; Ma D; Cai X
Tumour Biol; 2014 Nov; 35(11):10759-64. PubMed ID: 25073510
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma.
Tu K; Liu Z; Yao B; Han S; Yang W
Int J Oncol; 2016 Mar; 48(3):965-74. PubMed ID: 26708293
[TBL] [Abstract][Full Text] [Related]
8. LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3.
Shu G; Su H; Wang Z; Lai S; Wang Y; Liu X; Dai L; Bi Y; Chen W; Huang W; Zhou Z; He S; Dai H; Tang B
J Exp Clin Cancer Res; 2021 Jan; 40(1):45. PubMed ID: 33499874
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.
Chen JS; Li HS; Huang JQ; Dong SH; Huang ZJ; Yi W; Zhan GF; Feng JT; Sun JC; Huang XH
Cancer Lett; 2016 May; 375(1):73-83. PubMed ID: 26944318
[TBL] [Abstract][Full Text] [Related]
10. miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.
Chen M; Hu W; Xiong CL; Qu Z; Yin CQ; Wang YH; Luo CL; Guan Q; Yuan CH; Wang FB
Oncotarget; 2016 Dec; 7(49):80751-80764. PubMed ID: 27811373
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma.
Yang H; Fang F; Chang R; Yang L
Hepatology; 2013 Jul; 58(1):205-17. PubMed ID: 23401231
[TBL] [Abstract][Full Text] [Related]
12. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM
Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of E2F transcription factor 3 is associated with poor prognosis in hepatocellular carcinoma.
Zeng X; Yin F; Liu X; Xu J; Xu Y; Huang J; Nan Y; Qiu X
Oncol Rep; 2014 Mar; 31(3):1139-46. PubMed ID: 24402082
[TBL] [Abstract][Full Text] [Related]
14. ANT2 shRNA downregulates miR-19a and miR-96 through the PI3K/Akt pathway and suppresses tumor growth in hepatocellular carcinoma cells.
Baik SH; Lee J; Lee YS; Jang JY; Kim CW
Exp Mol Med; 2016 Mar; 48(3):e222. PubMed ID: 27012708
[TBL] [Abstract][Full Text] [Related]
15. Increase of miR-199a-5p by protoporphyrin IX, a photocatalyzer, directly inhibits E2F3, sensitizing mesenchymal tumor cells to anti-cancer agents.
Lee JM; Heo MJ; Lee CG; Yang YM; Kim SG
Oncotarget; 2015 Feb; 6(6):3918-31. PubMed ID: 25714015
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
17. miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma.
Lian J; Jing Y; Dong Q; Huan L; Chen D; Bao C; Wang Q; Zhao F; Li J; Yao M; Qin L; Liang L; He X
Oncotarget; 2016 Jan; 7(3):2672-83. PubMed ID: 26684241
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.
Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P
Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL
FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
